Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Evoke Pharma, Inc. develops and commercializes specialized gastrointestinal drugs, primarily focusing on Gimoti, a nasal spray for diabetic gastroparesis. The company partners with Eversana for marketing and distribution, targeting healthcare providers and patients. Its business model emphasizes innovative drug delivery, intellectual property protection, and strategic partnerships to address unmet needs in GI motility disorders within the U.S. healthcare market.
This description was generated via AI from an annual report. Updated about 1 year ago.